Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2023 年第 4 季持倉
持倉截至 2023/12/31，2024/2/13 申報。只含多頭部位，變化是跟 2023 年第 3 季比股數。
- 持股檔數
- 73
- 較 2023 年第 3 季 +4
- 總值
- $5.02 億
- 較 2023 年第 3 季 +$1.95 億 (+63.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 1,404,608 | $4,165 萬 | 8.3% | +1,404,608 | 新進 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 750,000 | $3,180 萬 | 6.3% | +64,939+9.5% | 加碼 | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,090,441 | $2,576 萬 | 5.1% | −38,935−3.4% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $2,314 萬 | 4.6% | +15,000+17.6% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 460,000 | $2,119 萬 | 4.2% | +159,562+53.1% | 加碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $2,058 萬 | 4.1% | – | – | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,900,000 | $1,984 萬 | 4.0% | −100,000−5.0% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 340,000 | $1,887 萬 | 3.8% | −60,000−15.0% | 減碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 3,779,694 | $1,690 萬 | 3.4% | +3,107,337+462.2% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 447,095 | $1,591 萬 | 3.2% | −2,905−0.6% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 400,000 | $1,586 萬 | 3.2% | +250,000+166.7% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 537,093 | $1,501 萬 | 3.0% | −508,017−48.6% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 345,000 | $1,453 萬 | 2.9% | +45,000+15.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 160,000 | $1,336 萬 | 2.7% | −70,366−30.5% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 175,000 | $1,288 萬 | 2.6% | +125,000+250.0% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,466,465 | $1,126 萬 | 2.2% | +466,165+46.6% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 563,824 | $1,121 萬 | 2.2% | +195,495+53.1% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 517,554 | $1,114 萬 | 2.2% | +275,257+113.6% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,550,408 | $998.5 萬 | 2.0% | −442,058−22.2% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 356,384 | $988.6 萬 | 2.0% | +256,384+256.4% | 加碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 1,885,802 | $803.4 萬 | 1.6% | +505,950+36.7% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 690,112 | $712.2 萬 | 1.4% | +440,112+176.0% | 加碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 795,729 | $633.4 萬 | 1.3% | −222,362−21.8% | 減碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 228,277 | $591.0 萬 | 1.2% | −10,831−4.5% | 減碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 100,049 | $587.8 萬 | 1.2% | +39,623+65.6% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 500,000 | $561.5 萬 | 1.1% | +350,000+233.3% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 300,000 | $558.3 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| SVRASavara Inc | COM | 1,150,000 | $540.5 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 550,000 | $481.3 萬 | 1.0% | +550,000 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 75,000 | $448.9 萬 | 0.9% | +35,000+87.5% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 70,988 | $428.7 萬 | 0.9% | +20,988+42.0% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 300,000 | $419.4 萬 | 0.8% | +100,000+50.0% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $404.1 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 50,000 | $397.9 萬 | 0.8% | +50,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 100,000 | $365.0 萬 | 0.7% | +58,419+140.5% | 加碼 | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $360.0 萬 | 0.7% | – | 新進 | – |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $340.3 萬 | 0.7% | – | 新進 | – |
| RLAYRelay Therapeutics, Inc. | COM | 300,000 | $330.3 萬 | 0.7% | +300,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 80,000 | $323.0 萬 | 0.6% | +50,000+166.7% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 25,000 | $310.1 萬 | 0.6% | −32,500−56.5% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 300,000 | $305.7 萬 | 0.6% | +300,000 | 新進 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 300,274 | $297.3 萬 | 0.6% | −49,726−14.2% | 減碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 7,500 | $285.3 萬 | 0.6% | +7,500 | 新進 | 歷史 |
| KURAKura Oncology, Inc. | COM | 191,535 | $275.4 萬 | 0.5% | −665,000−77.6% | 減碼 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 109,900 | $254.0 萬 | 0.5% | +109,900 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $251.9 萬 | 0.5% | −26,400−56.9% | 減碼 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,000,000 | $232.0 萬 | 0.5% | −1,850,000−64.9% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 200,000 | $210.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PENPenumbra Inc | COM | 7,500 | $188.7 萬 | 0.4% | +7,500 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 68,081 | $178.2 萬 | 0.4% | +68,081 | 新進 | 歷史 |
| ADCTADC Therapeutics SA | SHS | 1,013,540 | $168.2 萬 | 0.3% | −86,460−7.9% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 25,000 | $157.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 125,969 | $154.3 萬 | 0.3% | −152,323−54.7% | 減碼 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 50,000 | $147.6 萬 | 0.3% | +20,000+66.7% | 加碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 125,000 | $139.6 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 10,000 | $131.8 萬 | 0.3% | +10,000 | 新進 | 歷史 |
| NARIInari Medical, Inc. | Stock | 20,000 | $129.8 萬 | 0.3% | +20,000 | 新進 | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 400,000 | $128.4 萬 | 0.3% | +400,000 | 新進 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 42,670 | $123.2 萬 | 0.2% | −227,330−84.2% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 50,000 | $108.9 萬 | 0.2% | +50,000 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 20,866 | $89.3 萬 | 0.2% | −9,290−30.8% | 減碼 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 202,349 | $87.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 125,000 | $84.4 萬 | 0.2% | +125,000 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 500,000 | $68.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $54.7 萬 | 0.1% | 00.0% | 不變 | – |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 137,000 | $42.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 66,000 | $42.8 萬 | 0.1% | −259,000−79.7% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $37.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 328,817 | $37.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IFRXInflaRx N.V. | COM | 200,097 | $32.6 萬 | 0.1% | −125,000−38.5% | 減碼 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 265,958 | $30.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ARAVAravive, Inc. | COM | 346,511 | $4.29 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $3.67 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（9 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $1,462 萬 |
| EYPTEyePoint, Inc. | COM NEW | $739.8 萬 | – |
| ESTAEstablishment Labs Holdings Inc. | COM | – | $582.5 萬 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $574.2 萬 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | – | $407.6 萬 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | $335.5 萬 | – |
| FLNAFilana Therapeutics, Inc. | COM | – | $272.4 萬 |
| APLSApellis Pharmaceuticals, Inc. | COM | – | $149.7 萬 |
| ALKSAlkermes plc. | SHS | $74.9 萬 | – |
2023 年第 3 季之後清倉（12 檔）
2023 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 3 季股數 | 2023 年第 3 季市值 | 2023 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | 79,214 | $382.2 萬 | 1.2% | 歷史 |
| SGENSeagen Inc. | COM | 10,000 | $212.2 萬 | 0.7% | 歷史 |
| LNTHLantheus Holdings, Inc. | Stock | 30,000 | $208.4 萬 | 0.7% | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 6,293 | $124.9 萬 | 0.4% | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 400,000 | $112.4 萬 | 0.4% | 歷史 |
| THRXTheseus Pharmaceuticals, Inc. | COM | 400,726 | $107.8 萬 | 0.4% | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 335,068 | $103.9 萬 | 0.3% | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 100,000 | $89.4 萬 | 0.3% | 歷史 |
| PODDInsulet Corp | Stock | 5,000 | $79.7 萬 | 0.3% | 歷史 |
| BCABBioAtla, Inc. | COM | 180,000 | $30.6 萬 | 0.1% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 44,348 | $29.6 萬 | 0.1% | 歷史 |
| NLS Pharmaceutics LtdH57830103 | SHS | 200,455 | $14.0 萬 | <0.1% | – |